4.3 Article

Heat inactivation of SARS-CoV 2 enabled the measurement of salivary cortisol during COVID-19 pandemic

Related references

Note: Only part of the references are listed.
Review Microbiology

Therapeutics for COVID-19

Sima S. Toussi et al.

Summary: This article reviews therapeutics for COVID-19 and their development, including prospects for anticoronavirals. Vaccines and monoclonal antibody treatments were available within a year, but there was still a need for therapeutics for certain patient groups. Investigational therapies showed mixed results, with some reducing viral load or preventing death. Nirmatrelvir-ritonavir and molnupiravir received Emergency Use Authorization in the United States. Immunomodulatory drugs targeting host-driven symptoms are also used. The article highlights the development of COVID-19 therapies and the challenges in developing anticoronavirals.

NATURE MICROBIOLOGY (2023)

Article Biotechnology & Applied Microbiology

Assessment of inactivation procedures for SARS-CoV-2

Heidi Auerswald et al.

Summary: Proper handling of samples infected with SARS-CoV-2 is crucial, especially in resource-limited settings where chemical and physical inactivation techniques can effectively reduce the risk of handling live virus.

JOURNAL OF GENERAL VIROLOGY (2021)

Article Endocrinology & Metabolism

Tele-medicine versus face-to-face consultation in Endocrine Outpatients Clinic during COVID-19 outbreak: a single-center experience during the lockdown period

F. Ceccato et al.

Summary: The emergency plan tailored for outpatients with endocrine diseases in response to the COVID-19 outbreak in Italy was effective in ensuring continued follow-up care for patients, with 86% of patients contacted receiving a clinical response. The cancellation rate of visits decreased significantly after the implementation of endocrine triage, indicating the plan's usefulness in maintaining continuity of care for outpatients.

JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION (2021)

Review Endocrinology & Metabolism

Consensus on diagnosis and management of Cushing's disease: a guideline update

Maria Fleseriu et al.

Summary: Cushing's disease requires accurate diagnosis, careful treatment selection, and long-term management. The Pituitary Society convened a consensus workshop to discuss recent evidence and clinical practice. Recommendations regarding lab tests, imaging, and treatment options were collated and discussed, with focus on future research topics.

LANCET DIABETES & ENDOCRINOLOGY (2021)

Review Endocrinology & Metabolism

Frequently Asked Questions in Patients With Adrenal Insufficiency in the Time of COVID-19

Chiara Sabbadin et al.

Summary: Adrenal insufficiency (AI) patients face the challenge of infection risk, especially during the COVID-19 pandemic. Prompt contact with the Endocrine center, comprehensive understanding of the diseases, and vaccination are crucial. Collaboration among physicians is essential in advising AI patients.

FRONTIERS IN ENDOCRINOLOGY (2021)

Article Immunology

Evaluation of stability and inactivation methods of SARS-CoV-2 in context of laboratory settings

Marek Widera et al.

Summary: The study evaluated the ability of commonly used lysis buffers in molecular biological laboratories to inactivate SARS-CoV-2, as well as analyzed viral stability in cell culture media and on display surfaces in a laboratory environment. Various chemical and non-chemical inactivation methods were also assessed, and it was found that certain detergent-containing lysis buffers were effective in inactivating the virus while others were not. Use of additional inactivation steps may be necessary before handling lysed viral samples from BSL-3.

MEDICAL MICROBIOLOGY AND IMMUNOLOGY (2021)

Article Multidisciplinary Sciences

Inactivation of SARS-CoV-2 virus in saliva using a guanidium based transport medium suitable for RT-PCR diagnostic assays

Sukalyani Banik et al.

Summary: The guanidium thiocyanate-based buffer eNAT showed effective inactivation of SARS-CoV-2 virus and stability of viral RNA, making it a valuable medium for transporting and processing clinical samples for RT-PCR detection of SARS-CoV-2.

PLOS ONE (2021)

Article Endocrinology & Metabolism

Low-dose short synacthen test with salivary cortisol in patients with suspected central adrenal insufficiency

Filippo Ceccato et al.

Summary: The low-dose short synacthen test (LDSST) is recommended for patients suspected of central adrenal insufficiency (AI), evaluating salivary cortisol levels before and after administering synacthen. The peak salivary cortisol level of >12.1 nmol/L after the test can indicate an intact HPA axis, helping to avoid unnecessary glucocorticoid replacement treatment.

ENDOCRINE CONNECTIONS (2021)

Article Endocrinology & Metabolism

Use of late-night salivary cortisol to monitor response to medical treatment in Cushing's disease

John Newell-Price et al.

EUROPEAN JOURNAL OF ENDOCRINOLOGY (2020)

Article Endocrinology & Metabolism

ENDOCRINOLOGY IN THE TIME OF COVID-19 Management of Cushing's syndrome

John Newell-Price et al.

EUROPEAN JOURNAL OF ENDOCRINOLOGY (2020)

Editorial Material Endocrinology & Metabolism

COVID-19 infection and glucocorticoids: update from the Italian Society of Endocrinology Expert Opinion on steroid replacement in adrenal insufficiency

A. M. Isidori et al.

JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION (2020)

Review Dentistry, Oral Surgery & Medicine

Saliva in the Diagnosis of COVID-19: A Review and New Research Directions

L. L. Fernandes et al.

JOURNAL OF DENTAL RESEARCH (2020)

Article Immunology

Methods of Inactivation of SARS-CoV-2 for Downstream Biological Assays

Edward Patterson et al.

JOURNAL OF INFECTIOUS DISEASES (2020)

Letter Infectious Diseases

Stability of SARS-CoV-2 in different environmental conditions

Alex W. H. Chin et al.

LANCET MICROBE (2020)

Article Endocrinology & Metabolism

The Low-Dose ACTH Test: Usefulness of Combined Analysis of Serum and Salivary Maximum Cortisol Response in Pediatrics

Elisa Vaiani et al.

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2019)

Review Medical Laboratory Technology

Central adrenal insufficiency: open issues regarding diagnosis and glucocorticoid treatment

Filippo Ceccato et al.

CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2019)

Article Endocrinology & Metabolism

Improved salivary cortisol rhythm with dual-release hydrocortisone

Filippo Ceccato et al.

ENDOCRINE CONNECTIONS (2018)

Article Endocrinology & Metabolism

Daily salivary cortisol and cortisone rhythm in patients with adrenal incidentaloma

Filippo Ceccato et al.

ENDOCRINE (2018)

Article Endocrinology & Metabolism

Diagnosis and Treatment of Primary Adrenal Insufficiency: An Endocrine Society Clinical Practice Guideline

Stefan R. Bornstein et al.

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2016)

Article Endocrinology & Metabolism

Performance of salivary cortisol in the diagnosis of Cushing's syndrome, adrenal incidentaloma, and adrenal insufficiency

Filippo Ceccato et al.

EUROPEAN JOURNAL OF ENDOCRINOLOGY (2013)

Article Endocrinology & Metabolism

Assessment of glucocorticoid therapy with salivary cortisol in secondary adrenal insufficiency

Filippo Ceccato et al.

EUROPEAN JOURNAL OF ENDOCRINOLOGY (2012)

Review Endocrinology & Metabolism

Utility of Salivary Cortisol Measurements in Cushing's Syndrome and Adrenal Insufficiency

Hershel Raff

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2009)

Review Medical Laboratory Technology

Current Status of Salivary Hormone Analysis

Michael Groeschl

CLINICAL CHEMISTRY (2008)

Article Endocrinology & Metabolism

Midnight Salivary Cortisol Determination for Assessing the Outcome of Transsphenoidal Surgery in Cushing's Disease

Carmen A. Carrasco et al.

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2008)

Article Endocrinology & Metabolism

Low-dose ACTH (1 μg) salivary test:: a potential alternative to the classical blood test

Y Marcus-Perlman et al.

CLINICAL ENDOCRINOLOGY (2006)